DK Delek US posts blowout Q4 2025 EPS results far above estimates while shares dip 04 percent today PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower Vanguard Financials Index Fund ETF VFH Q1 2026 Big Bank Earnings Catalyst Bullish Upside Amid Steeper Yield Curve Tailwinds